Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Addresses the Needs of Medical THC Users
Lexaria’s THC absorption animal study yielded promising results on the patented DehydraTECH(TM) technologyIt showed that the technology required a shorter time to deliver the same THC levels than concentration-matched controlsLexaria believes that through DehydraTECH, it is meeting the needs of medical THC users with its rapid delivery, increased overall THC delivery and high brain tissue delivery Lexaria Bioscience's (NASDAQ: LEXX) just-concluded oral tetrahydrocannabinol (“THC”) absorption…